Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001633 · ClinicalTrials.gov registry record · Phase 2
Safety and Effectiveness of Coronary Magnetic Resonance Angiography (CMRA) Imaging
A Phase 2 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00001633 is a Phase 2 study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 20 participants.
The verdict
NCT00001633, a Phase 2 study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Magnetic resonance imaging (MRI) is a diagnostic tool that creates high quality images of the human body without the use of X-ray (radiation). MRI is especially useful when studying the arteries of the heart (CMRA, coronary magnetic resonance angiography). In this study researchers from several laboratories and hospitals will work together to determine the safety and effectiveness of CMRA with MS-325. MS-325 is a contrast agent. It is given to patients undergoing CRMA in order to improve the appearance of the arteries of the heart.
Interventions
- PROCEDURE Coronary magnetic resonance angiography imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 1997-09 |
| Est. Completion | 2000-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001633
The ClinicalTrials.gov registry entry for NCT00001633 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coronary magnetic resonance angiography imaging is the first listed.
NCT00001633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001633 about?
NCT00001633 is a clinical study titled "Safety and Effectiveness of Coronary Magnetic Resonance Angiography (CMRA) Imaging". Magnetic resonance imaging (MRI) is a diagnostic tool that creates high quality images of the human body without the use of X-ray (radiation). MRI is especially useful when studying the arteries of the heart (CMRA, coronary magnetic resonance angiography). In this study researchers from several lab...
What is the current status of trial NCT00001633?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 1997-09. Estimated completion is 2000-12.
What interventions are being tested in trial NCT00001633?
The interventions under investigation include: Coronary magnetic resonance angiography imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00001633?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.